In last trading session, Apyx Medical Corp (NASDAQ:APYX) saw 0.31 million shares changing hands with its beta currently measuring 1.18. Company’s recent per share price level of $2.40 trading at $0.31 or 14.83% at ring of the bell on the day assigns it a market valuation of $83.14M. That closing price of APYX’s stock is at a discount of -232.08% from its 52-week high price of $7.97 and is indicating a premium of 45.42% from its 52-week low price of $1.31. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.3 million shares which gives us an average trading volume of 144.45K if we extend that period to 3-months.
For Apyx Medical Corp (APYX), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 1.80. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.15 in the current quarter.
Apyx Medical Corp (NASDAQ:APYX) trade information
Upright in the green during last session for gaining 14.83%, in the last five days APYX remained trading in the green while hitting it’s week-highest on Friday, 11/17/23 when the stock touched $2.40 price level, adding 6.98% to its value on the day. Apyx Medical Corp’s shares saw a change of 2.56% in year-to-date performance and have moved 36.75% in past 5-day. Apyx Medical Corp (NASDAQ:APYX) showed a performance of -9.43% in past 30-days. Number of shares sold short was 2.22 million shares which calculate 14.4 days to cover the short interests.
Apyx Medical Corp (APYX) estimates and forecasts
Statistics highlight that Apyx Medical Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -61.66% of value to its shares in past 6 months, showing an annual growth rate of 44.78% while that of industry is 14.90. Apart from that, the company came raising its revenue forecast for fiscal year 2023. The company is estimating its revenue growth to increase by 11.80% in the current quarter and calculating -30.00% decrease in the next quarter. This year revenue growth is estimated to rise 19.80% from the last financial year’s standing.
4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $15.62 million for the same. And 4 analysts are in estimates of company making revenue of $14.5 million in the next quarter that will end on Mar 2024. Company posted $12.61 million and $12.14 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 23.90% while estimating it to be 19.40% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -32.11% during past 5 years. In 2023, company’s earnings growth rate is likely to be around 39.10% while estimates for its earnings growth in next 5 years are of 15.00%.
Apyx Medical Corp is more likely to be releasing its next quarterly report on November 09 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Apyx Medical Corp (NASDAQ:APYX)’s Major holders
Insiders are in possession of 12.73% of company’s total shares while institution are holding 72.27 percent of that, with stock having share float percentage of 82.81%. Investors also watch the number of corporate investors in a company very closely, which is 72.27% institutions for Apyx Medical Corp that are currently holding shares of the company. Archon Capital Management LLC is the top institutional holder at APYX for having 3.45 million shares of worth $17.36 million. And as of Jun 29, 2023, it was holding 9.96% of the company’s outstanding shares.
The second largest institutional holder is Divisadero Street Capital Management, LP, which was holding about 2.28 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 6.59% of outstanding shares, having a total worth of $11.49 million.
On the other hand, Vanguard Total Stock Market Index Fund and RENN Fund, Inc. are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 1.02 million shares of worth $5.11 million or 2.93% of the total outstanding shares. The later fund manager was in possession of 0.61 million shares on Jun 29, 2023, making its stake of worth around $3.09 million in the company or a holder of 1.78% of company’s stock.